Serum androgens and prostate cancer risk: results from the placebo arm of the Prostate Cancer Prevention Trial

Author:

Schenk Jeannette M.,Till Cathee,Hsing Ann W.,Stanczyk Frank Z.,Gong Zhihong,Neuhouser Marian L.,Reichardt Juergen K.,Hoque Ashraful M.,Figg William D.,Goodman Phyllis J.,Tangen Catherine M.,Thompson Ian M.

Funder

National Cancer Institute

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology

Reference28 articles.

1. Huggins C, Hodges CV (1941) Studies on prostatic cancer: I. The effect of castration, of estrogen and of androgen injection on serum phosphatases in metastatic carcinoma of the prostate. Cancer Res 1:293–297

2. Pollard M, Luckert PH, Schmidt MA (1982) Induction of prostate adenocarcinomas in Lobund Wistar rats by testosterone. Prostate 3:563–568

3. Sharifi N, Gulley JL, Dahut WL (2005) Androgen deprivation therapy for prostate cancer. JAMA 294:238–244

4. Hsing AW, Chu LW, Stanczyk FZ (2008) Androgen and prostate cancer: is the hypothesis dead? Cancer Epidemiol Biomark Prev 17:2525–2530

5. Hsing AW, Comstock GW (1993) Serological precursors of cancer: serum hormones and risk of subsequent prostate cancer. Cancer Epidemiol Biomark Prev 2:27–32

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3